Ischemic heart disease Board decisions

The Board denied a rating higher than 30 percent for ischemic heart disease (IHD) prior to June 8, 2023, and remanded the claim for a rating more than 60 percent.

The Board granted service connection for hypertension, type II diabetes mellitus, and ischemic heart disease. The claims for renal cell carcinoma in remission and coronary artery disease were also granted as secondary to the Veteran's service-connected hypertension.

The Board granted service connection for coronary artery disease (CAD) as secondary to the Veteran's service-connected HIV related illness with AIDS related opportunistic infection.

The Board denied the Veteran's claim for an initial rating in excess of 10 percent for service-connected MI with CAD and atrial fibrillation associated with herbicide exposure, as the evidence did not show a workload of greater than 5.0 METs but not greater than 7.0 METs or cardiac hypertrophy or dilatation.

The Board remands the claims for service connection for colitis, heart disease, hypertension, gout, and a kidney condition due to inadequate VA nexus opinions.

The Board remanded the claim for service connection of coronary artery disease (CAD) to obtain outstanding private treatment records and schedule a VA examination.

The veteran's claim for service connection for GERD was granted. The claims for atypical chest pain and heart palpitation/heart condition were remanded for further development.

The Board's decision to remand the veteran's claims for coronary artery disease ratings was vacated because the veteran could not have initiated an appeal under the legacy system.

The appeal of entitlement to service connection for coronary artery disease (CAD) was dismissed as the benefit sought on appeal has been granted in full.

The Board denied the veteran's claims for earlier effective dates and higher disability ratings, finding that the evidence did not support a more favorable outcome.

The Board granted a 10 percent evaluation for hypertension and denied an initial compensable evaluation for hypothyroidism, as well as higher ratings for coronary artery disease. Service connection was denied for a bladder disability, diverticulosis, and a neck disability.

The Board granted an earlier effective date of October 23, 2018 for service connection for obstructive sleep apnea and restored a 60 percent evaluation for hypertensive heart disease from April 14, 2022 to March 31, 2023. The claims for increased ratings for erectile dysfunction and obstructive sleep apnea were denied.

The Board granted service connection for prostate cancer, coronary artery disease, and hypertension due to herbicide exposure during the Veteran's active service in Korea.

The Board denied increased ratings for ischemic heart disease and right knee replacement with residuals, and remanded claims for service connection for neuropathy of the hands, feet, and erectile dysfunction.

The Board remands the service connection claims for coronary heart disease, diabetes, and knee degenerative disease due to a pre-decisional duty to assist error.

The Board denied all initial rating claims for various disabilities, finding that the evidence did not support higher ratings.

The Board remanded all issues related to service connection for various disabilities, including heart disability and peripheral neuropathies. The Veteran's claims are being sent back for additional development.

The Board remanded the case to determine if the veteran's dishonorable discharge bars VA benefits and to reevaluate service connection for body pain, right knee disability, heart disability, and sleep apnea.

The veteran's claim for an earlier effective date and higher ratings for coronary artery disease was partially granted. The veteran received a 60% rating from December 28, 2017 to August 14, 2020 but was denied other requested increases.

The Board remands the claims for service connection for coronary artery disease and hypertension due to an inadequate VA medical opinion regarding their relationship to toxic exposures during active duty.